Aberrant Epicardial Adipose Tissue Extracellular Matrix Remodeling in Patients with Severe Ischemic Cardiomyopathy: Insight from Comparative Quantitative Proteomics

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Jiang, Ding Sheng ^a   Zeng, Hao Long ^a   Li, Rui ^a   Huo, Bo ^a   Su, Yun Shu ^a   Fang, Jing ^a   Yang, Qing ^b   Liu, Li Gang ^a   Hu, Min ^a   Cheng, Cai ^a   Zhu, Xue Hai ^a   Yi, Xin ^b,c,d   Wei, Xiang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN UNIVERSITY   (China)

^c RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^d HUBEI KEY LABORATORY OF CARDIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; PROTEOME;

ADIPOSE TISSUE; CARDIOMYOPATHY; COMPARATIVE STUDY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GENE REGULATORY NETWORK; GENETICS; HEART MUSCLE ISCHEMIA; HUMAN; MALE; METABOLISM; MIDDLE AGED; PERICARDIUM; PROCEDURES; PROTEIN ANALYSIS; PROTEOMICS; SIGNAL TRANSDUCTION;

ADIPOSE TISSUE; CARDIOMYOPATHIES; COLLAGEN; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GENE REGULATORY NETWORKS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PERICARDIUM; PROTEIN INTERACTION MAPS; PROTEOME; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 85014629560     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep43787     Document Type: Article

References (49)

1. Iacobellis, G., Corradi, D. & Sharma, A. M. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2, 536-543, doi: 10.1038/ncpcardio0319 (2005).
2. Talman, A. H. et al. Epicardial adipose tissue: far more than a fat depot. Cardiovasc Diagn Ther 4, 416-429, doi: 10.3978/j.issn.2223-3652.2014.11.05 (2014).
3. Iacobellis, G. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol 11, 363-371, doi: 10.1038/nrendo.2015.58 (2015).
4. Eroglu, S. et al. Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. Nutr Metab Cardiovasc Dis 19, 211-217, doi: 10.1016/j.numecd.2008.05.002 (2009).
5. Wong, C. X., Ganesan, A. N. & Selvanayagam, J. B. Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions. Eur Heart J, doi: 10.1093/eurheartj/ehw045 (2016).
6. Iacobellis, G., Zaki, M. C., Garcia, D. & Willens, H. J. Epicardial fat in atrial fibrillation and heart failure. Horm Metab Res 46, 587-590, doi: 10.1055/s-0034-1367078 (2014).
7. Iacobellis, G. et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 88, 5163-5168, doi: 10.1210/jc.2003-030698 (2003).
8. Kremen, J. et al. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J Clin Endocrinol Metab 91, 4620-4627, doi: 10.1210/jc.2006-1044 (2006).
9. Mahabadi, A. A. et al. Association of epicardial adipose tissue with progression of coronary artery calcification is more pronounced in the early phase of atherosclerosis: results from the Heinz Nixdorf recall study. JACC Cardiovasc Imaging 7, 909-916, doi: 10.1016/j.jcmg.2014.07.002 (2014).
10. Hajsadeghi, F. et al. Increased epicardial adipose tissue is associated with coronary artery disease and major adverse cardiovascular events. Atherosclerosis 237, 486-489, doi: 10.1016/j.atherosclerosis.2014.09.037 (2014).
11. Iacobellis, G. Epicardial fat: a new cardiovascular therapeutic target. Curr Opin Pharmacol 27, 13-18, doi: 10.1016/j. coph.2016.01.004 (2016).
12. Pezeshkian, M. et al. Fatty acid composition of epicardial and subcutaneous human adipose tissue. Metab Syndr Relat Disord 7, 125-131 (2009).
13. Fitzgibbons, T. P. & Czech, M. P. Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations. J Am Heart Assoc 3, e000582, doi: 10.1161/JAHA.113.000582 (2014).
14. Han, S. H., Sakuma, I., Shin, E. K. & Koh, K. K. Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies. Prog Cardiovasc Dis 52, 126-140, doi: 10.1016/j.pcad.2009.06.004 (2009).
15. Sacks, H. S. et al. Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat. J Clin Endocrinol Metab 94, 3611-3615, doi: 10.1210/jc.2009-0571 (2009).
16. Prati, F. et al. Eccentric atherosclerotic plaques with positive remodelling have a pericardial distribution: a permissive role of epicardial fat? A three-dimensional intravascular ultrasound study of left anterior descending artery lesions. Eur Heart J 24, 329-336 (2003).
17. Mazurek, T. et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108, 2460-2466, doi: 10.1161/01.CIR.0000099542.57313.C5 (2003).
18. Hirata, Y. et al. Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J Am Coll Cardiol 58, 248-255, doi: 10.1016/j.jacc.2011.01.048 (2011).
19. Shimabukuro, M. et al. Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 33, 1077-1084, doi: 10.1161/ATVBAHA.112.300829 (2013).
20. Chechi, K., Blanchard, P. G., Mathieu, P., Deshaies, Y. & Richard, D. Brown fat like gene expression in the epicardial fat depot correlates with circulating HDL-cholesterol and triglycerides in patients with coronary artery disease. Int J Cardiol 167, 2264-2270, doi: 10.1016/j.ijcard.2012.06.008 (2013).
21. Dozio, E. et al. Increased reactive oxygen species production in epicardial adipose tissues from coronary artery disease patients is associated with brown-to-white adipocyte trans-differentiation. Int J Cardiol 174, 413-414, doi: 10.1016/j.ijcard.2014.04.045 (2014).
22. Aydin, A. M., Kayali, A., Poyraz, A. K. & Aydin, K. The relationship between coronary artery disease and pericoronary epicardial adipose tissue thickness. J Int Med Res 43, 17-25, doi: 10.1177/0300060514558323 (2015).
23. Lu, J. et al. Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophy. Basic Res Cardiol 108, 326, doi: 10.1007/s00395-012-0326-9 (2013).
24. Rose, B. A., Force, T. & Wang, Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 90, 1507-1546, doi: 10.1152/physrev.00054.2009 (2010).
25. Mariman, E. C. & Wang, P. Adipocyte extracellular matrix composition, dynamics and role in obesity. Cell Mol Life Sci 67, 1277-1292, doi: 10.1007/s00018-010-0263-4 (2010).
26. Uchida, Y. et al. Human pericoronary adipose tissue as storage and possible supply site for oxidized low-density lipoprotein and high-density lipoprotein in coronary artery. J Cardiol, doi: 10.1016/j.jjcc.2016.03.015 (2016).
27. Namiki, A. et al. Endothelin-1 concentrations in pericardial fluid are more elevated in patients with ischemic heart disease than in patients with nonischemic heart disease. Jpn Heart J 44, 633-644 (2003).
28. Corda, S. et al. Trophic effect of human pericardial fluid on adult cardiac myocytes. Differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy. Circ Res 81, 679-687 (1997).
29. Bechtloff, R. et al. Gender and age-dependent differences in the bradykinin-degradation within the pericardial fluid of patients with coronary artery disease. Int J Cardiol 146, 164-170, doi: 10.1016/j.ijcard.2009.06.028 (2011).
30. McAninch, E. A. et al. Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease. Obesity (Silver Spring) 23, 1267-1278, doi: 10.1002/oby.21059 (2015).
31. Venteclef, N. et al. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipofibrokines. Eur Heart J 36, 795-805a, doi: 10.1093/eurheartj/eht099 (2015).
32. Divoux, A. & Clement, K. Architecture and the extracellular matrix: the still unappreciated components of the adipose tissue. Obes Rev 12, e494-503, doi: 10.1111/j.1467-789X.2010.00811.x (2011).
33. Henegar, C. et al. Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol 9, R14, doi: 10.1186/gb-2008-9-1-r14 (2008).
34. Khan, T. et al. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol 29, 1575-1591, doi: 10.1128/ MCB.01300-08 (2009).
35. Lin, Chun, T. H. & Kang, L. Adipose extracellular matrix remodelling in obesity and insulin resistance. Biochem Pharmacol, doi: 10.1016/j.bcp.2016.05.005 (2016).
36. Brener, M. et al. Epicardial fat is associated with duration of antiretroviral therapy and coronary atherosclerosis. Aids 28, 1635-1644, doi: 10.1097/qad.0000000000000116 (2014).
37. Pellegrinelli, V. et al. Human adipocyte function is impacted by mechanical cues. J Pathol 233, 183-195, doi: 10.1002/path.4347 (2014).
38. Pellegrinelli, V., Carobbio, S. & Vidal-Puig, A. Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues. Diabetologia 59, 1075-1088, doi: 10.1007/s00125-016-3933-4 (2016).
39. Abdennour, M. et al. Association of adipose tissue and liver fibrosis with tissue stiffness in morbid obesity: links with diabetes and BMI loss after gastric bypass. J Clin Endocrinol Metab 99, 898-907, doi: 10.1210/jc.2013-3253 (2014).
40. Jiang, D. S. et al. The potential role of lysosome-associated membrane protein 3 (LAMP3) on cardiac remodelling. Am J Transl Res 8, 37-48 (2016).
41. Jiang, D. S. et al. IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling. Nat Commun 5, 3303, doi: 10.1038/ncomms4303 (2014).
42. Jiang, D. S. et al. Signal regulatory protein-alpha protects against cardiac hypertrophy via the disruption of toll-like receptor 4 signaling. Hypertension 63, 96-104, doi: 10.1161/HYPERTENSIONAHA.113.01506 (2014).
43. Zeng, H. L. et al. Quantitative proteomics reveals olfactory input-dependent alterations in the mouse olfactory bulb proteome. J Proteomics 109C, 125-142, doi: 10.1016/j.jprot.2014.06.023 (2014).
44. Maere, S., Heymans, K. & Kuiper, M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21, 3448-3449, doi: 10.1093/bioinformatics/bti551 (2005).
45. Moriya, Y., Itoh, M., Okuda, S., Yoshizawa, A. C. & Kanehisa, M. KAAS: an automatic genome annotation and pathway reconstruction server. Nucleic Acids Res 35, W182-185, doi: 10.1093/nar/gkm321 (2007).
46. Jiang, D. S. et al. Interferon regulatory factor 1 is required for cardiac remodeling in response to pressure overload. Hypertension 64, 77-86, doi: 10.1161/HYPERTENSIONAHA.114.03229 (2014).
47. Jiang, D. S. et al. Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy. Hypertension 63, 713-722, doi: 10.1161/HYPERTENSIONAHA.113.02653 (2014).
48. Jiang, D. S. et al. Interferon regulatory factor 9 protects against cardiac hypertrophy by targeting myocardin. Hypertension 63, 119-127, doi: 10.1161/HYPERTENSIONAHA.113.02083 (2014).
49. Jiang, D. S. et al. Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy. Hypertension 61, 1193-1202, doi: 10.1161/HYPERTENSIONAHA.111.00614 (2013).